|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/137 | |
| A61K 31/4164 | |||
| A61K 31/4174 | |||
| A61K 31/498 | |||
| A61K 31/165 | |||
| A61K 9/00 | |||
| A61P 17/02 |
| (11) | Number of the document | 2994120 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14729541.4 |
| Date of filing the European patent application | 2014-05-05 | |
| (97) | Date of publication of the European application | 2016-03-16 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/036778 |
| Date | 2014-05-05 |
| (87) | Number | WO 2014/182610 |
| Date | 2014-11-13 |
| (30) | Number | Date | Country code |
| 201361819927 P | 2013-05-06 | US |
| (72) |
GIL, Daniel W., US
ANDREWS-JONES, Lydia L., US
HSIA, Edward C., US
TIAN, Mingting, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | ALPHA ADRENERGIC AGONISTS FOR THE TREATMENT OF TISSUE TRAUMA |
| ALPHA ADRENERGIC AGONISTS FOR THE TREATMENT OF TISSUE TRAUMA |